PATENT CLAIM ANALYSIS

Application Number: 15918117
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "130100"]

Abstract:
The present invention encompasses methods and compositions for  Ureaplasma  infection prevention and/or treatment. In specific cases, the invention concerns vaccines for  Ureaplasma , including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of  Ureaplasma.

Claim (Index 2):
A method of diagnosing  Ureaplasma  infection comprising the step of delivering the antibodies of  claim 1  to a sample, removing unbound antibodies and detecting the presence of specifically bound antibodies.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 90.0
- Lexical Diversity: 1.41176
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14968074', '14114703', '15674591', '14149670', '15317021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6808633848268505
- 35 USC 102 Novelty (BERT): 0.5679550908612322
- Combined Prediction Score: 0.6695725554302886
- Mean Citation Score: 298.173318
- Max Citation Score: 473.1609
- Similarity Product: 330.33115249135494

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test